

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sulfate transmembrane transport (GO:1902358) | 9.06743422 |
| 2 | sulfate transport (GO:0008272) | 7.50779270 |
| 3 | flavonoid metabolic process (GO:0009812) | 7.21258020 |
| 4 | cellular glucuronidation (GO:0052695) | 7.21222397 |
| 5 | glucuronate metabolic process (GO:0019585) | 6.85736147 |
| 6 | uronic acid metabolic process (GO:0006063) | 6.85736147 |
| 7 | bicarbonate transport (GO:0015701) | 6.38299281 |
| 8 | intestinal absorption (GO:0050892) | 6.35426939 |
| 9 | positive regulation of respiratory burst (GO:0060267) | 6.29516384 |
| 10 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.16389979 |
| 11 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.86192920 |
| 12 | sperm capacitation (GO:0048240) | 5.52777662 |
| 13 | renal system process involved in regulation of blood volume (GO:0001977) | 5.36410589 |
| 14 | regulation of guanylate cyclase activity (GO:0031282) | 5.35381504 |
| 15 | transcytosis (GO:0045056) | 5.33208597 |
| 16 | glucocorticoid biosynthetic process (GO:0006704) | 5.16226755 |
| 17 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 5.15143624 |
| 18 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 5.15143624 |
| 19 | glomerular filtration (GO:0003094) | 5.06614042 |
| 20 | oligosaccharide biosynthetic process (GO:0009312) | 5.05313433 |
| 21 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.03889687 |
| 22 | bile acid and bile salt transport (GO:0015721) | 4.98933977 |
| 23 | phenylpropanoid metabolic process (GO:0009698) | 4.78865461 |
| 24 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.66838494 |
| 25 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.62331948 |
| 26 | renal filtration (GO:0097205) | 4.58894749 |
| 27 | positive regulation of fatty acid oxidation (GO:0046321) | 4.55718075 |
| 28 | ethanol oxidation (GO:0006069) | 4.55148790 |
| 29 | regulation of vitamin metabolic process (GO:0030656) | 4.53080970 |
| 30 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.47979979 |
| 31 | O-glycan processing (GO:0016266) | 4.42072431 |
| 32 | negative regulation of myotube differentiation (GO:0010832) | 4.40145907 |
| 33 | regulation of intracellular pH (GO:0051453) | 4.37907879 |
| 34 | regulation of respiratory burst (GO:0060263) | 4.23991451 |
| 35 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.21991656 |
| 36 | one-carbon metabolic process (GO:0006730) | 4.20986994 |
| 37 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.17998645 |
| 38 | endocrine process (GO:0050886) | 4.17998645 |
| 39 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.17998645 |
| 40 | cGMP-mediated signaling (GO:0019934) | 4.05968415 |
| 41 | regulation of cellular pH (GO:0030641) | 4.04368990 |
| 42 | sulfur compound transport (GO:0072348) | 3.97730488 |
| 43 | lipid translocation (GO:0034204) | 3.88844997 |
| 44 | phospholipid translocation (GO:0045332) | 3.88844997 |
| 45 | desmosome organization (GO:0002934) | 3.86511335 |
| 46 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.85906605 |
| 47 | regulation of pH (GO:0006885) | 3.85600345 |
| 48 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.82087137 |
| 49 | regulation of cholesterol homeostasis (GO:2000188) | 3.80859762 |
| 50 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.74284652 |
| 51 | regulation of systemic arterial blood pressure (GO:0003073) | 3.67046957 |
| 52 | sodium ion homeostasis (GO:0055078) | 3.66523979 |
| 53 | drug transmembrane transport (GO:0006855) | 3.66322923 |
| 54 | intestinal epithelial cell development (GO:0060576) | 3.65798997 |
| 55 | ethanol metabolic process (GO:0006067) | 3.58350992 |
| 56 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 3.54381386 |
| 57 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 3.54381386 |
| 58 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 3.54381386 |
| 59 | monovalent inorganic cation homeostasis (GO:0055067) | 3.52647339 |
| 60 | response to acidic pH (GO:0010447) | 3.47534856 |
| 61 | epithelial structure maintenance (GO:0010669) | 3.46469477 |
| 62 | excretion (GO:0007588) | 3.45532486 |
| 63 | digestive system process (GO:0022600) | 3.43935210 |
| 64 | thrombin receptor signaling pathway (GO:0070493) | 3.41259500 |
| 65 | labyrinthine layer development (GO:0060711) | 3.41133821 |
| 66 | epoxygenase P450 pathway (GO:0019373) | 3.40728474 |
| 67 | positive regulation of pseudopodium assembly (GO:0031274) | 3.38256762 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 3.36571582 |
| 69 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.35588724 |
| 70 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.34786847 |
| 71 | cellular response to pH (GO:0071467) | 3.34401078 |
| 72 | cellular monovalent inorganic cation homeostasis (GO:0030004) | 3.32895877 |
| 73 | sulfur amino acid catabolic process (GO:0000098) | 3.31649329 |
| 74 | regulation of cGMP biosynthetic process (GO:0030826) | 3.30958231 |
| 75 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.16485378 |
| 76 | regulation of cellular extravasation (GO:0002691) | 3.15640311 |
| 77 | actin filament depolymerization (GO:0030042) | 3.15027500 |
| 78 | receptor recycling (GO:0001881) | 3.14371068 |
| 79 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.14120098 |
| 80 | intermediate filament organization (GO:0045109) | 3.08866423 |
| 81 | drug metabolic process (GO:0017144) | 3.08526075 |
| 82 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.07700149 |
| 83 | drug transport (GO:0015893) | 3.06798879 |
| 84 | regulation of pseudopodium assembly (GO:0031272) | 3.02103740 |
| 85 | membrane hyperpolarization (GO:0060081) | 2.99586616 |
| 86 | ketone body metabolic process (GO:1902224) | 2.94244184 |
| 87 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.93774335 |
| 88 | positive regulation of lipid catabolic process (GO:0050996) | 2.91591844 |
| 89 | inorganic anion transmembrane transport (GO:0098661) | 2.90970634 |
| 90 | regulation of membrane lipid distribution (GO:0097035) | 2.90749022 |
| 91 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.89923609 |
| 92 | auditory receptor cell differentiation (GO:0042491) | 2.89854840 |
| 93 | striated muscle atrophy (GO:0014891) | 2.87545368 |
| 94 | fucosylation (GO:0036065) | 2.85724950 |
| 95 | regulation of protein glycosylation (GO:0060049) | 2.80706228 |
| 96 | chloride transmembrane transport (GO:1902476) | 2.75849391 |
| 97 | eosinophil chemotaxis (GO:0048245) | 2.75506550 |
| 98 | protein O-linked glycosylation (GO:0006493) | 2.74905147 |
| 99 | sphingomyelin metabolic process (GO:0006684) | 2.74832176 |
| 100 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.74128613 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.30198901 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.86337233 |
| 3 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.80012931 |
| 4 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.72219660 |
| 5 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.66067476 |
| 6 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.63546056 |
| 7 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.37431037 |
| 8 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.37365004 |
| 9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.34997801 |
| 10 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.34942008 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.32938557 |
| 12 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.20782305 |
| 13 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.20503159 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.17977121 |
| 15 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.98032917 |
| 16 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.91631193 |
| 17 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.84895396 |
| 18 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.82836176 |
| 19 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.82395010 |
| 20 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.80393731 |
| 21 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.74311010 |
| 22 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.70486316 |
| 23 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.70064576 |
| 24 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.63618391 |
| 25 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.60316965 |
| 26 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.59365243 |
| 27 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.58364602 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.57386497 |
| 29 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.56368794 |
| 30 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.48724755 |
| 31 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.46119482 |
| 32 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.44478419 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.44436224 |
| 34 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.43611694 |
| 35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.41508321 |
| 36 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.39057045 |
| 37 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.35144611 |
| 38 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.33622918 |
| 39 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.33042688 |
| 40 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.32978441 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31328981 |
| 42 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.26818359 |
| 43 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.20369841 |
| 44 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.19945185 |
| 45 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.14492338 |
| 46 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.11410126 |
| 47 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10804043 |
| 48 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.10397927 |
| 49 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.10011088 |
| 50 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09969225 |
| 51 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07836765 |
| 52 | RXR_22108803_ChIP-Seq_LS180_Human | 1.07495042 |
| 53 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06719128 |
| 54 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.04913633 |
| 55 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00311316 |
| 56 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.99193555 |
| 57 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98845063 |
| 58 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94938123 |
| 59 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.94748051 |
| 60 | CJUN_26792858_Chip-Seq_BT549_Human | 0.94571148 |
| 61 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93574393 |
| 62 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.93032042 |
| 63 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.92405120 |
| 64 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.91863610 |
| 65 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.91858575 |
| 66 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91110206 |
| 67 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.90116440 |
| 68 | TP53_16413492_ChIP-PET_HCT116_Human | 0.88456789 |
| 69 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.87773788 |
| 70 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.87246474 |
| 71 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.86318187 |
| 72 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.85586482 |
| 73 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.85427288 |
| 74 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.84361483 |
| 75 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.83781472 |
| 76 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.82612588 |
| 77 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.81859205 |
| 78 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81256589 |
| 79 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80547150 |
| 80 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80439870 |
| 81 | VDR_22108803_ChIP-Seq_LS180_Human | 0.79334494 |
| 82 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.79011810 |
| 83 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78158693 |
| 84 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.77662501 |
| 85 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.77139097 |
| 86 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.76820979 |
| 87 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.75595775 |
| 88 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.74194352 |
| 89 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.74139293 |
| 90 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73943847 |
| 91 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.72878440 |
| 92 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.72846802 |
| 93 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.71825692 |
| 94 | AR_25329375_ChIP-Seq_VCAP_Human | 0.71226497 |
| 95 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.71099278 |
| 96 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.70857118 |
| 97 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.69979620 |
| 98 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.69941874 |
| 99 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.69344789 |
| 100 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.68819181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.43402128 |
| 2 | MP0004043_abnormal_pH_regulation | 5.65484722 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 4.59432238 |
| 4 | MP0003866_abnormal_defecation | 4.20365429 |
| 5 | MP0010352_gastrointestinal_tract_polyps | 3.59618554 |
| 6 | MP0004147_increased_porphyrin_level | 3.33884462 |
| 7 | MP0001664_abnormal_digestion | 3.33336697 |
| 8 | MP0001663_abnormal_digestive_system | 3.27269672 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 3.26863261 |
| 10 | MP0001765_abnormal_ion_homeostasis | 2.90073416 |
| 11 | MP0003868_abnormal_feces_composition | 2.88141258 |
| 12 | MP0004264_abnormal_extraembryonic_tissu | 2.87590633 |
| 13 | MP0005381_digestive/alimentary_phenotyp | 2.84248063 |
| 14 | MP0005365_abnormal_bile_salt | 2.67556706 |
| 15 | MP0000477_abnormal_intestine_morphology | 2.59800818 |
| 16 | MP0003183_abnormal_peptide_metabolism | 2.54579556 |
| 17 | MP0010155_abnormal_intestine_physiology | 2.54454956 |
| 18 | MP0001873_stomach_inflammation | 2.49737239 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.43112222 |
| 20 | MP0000490_abnormal_crypts_of | 2.36603985 |
| 21 | MP0005670_abnormal_white_adipose | 2.16954005 |
| 22 | MP0009379_abnormal_foot_pigmentation | 2.14740277 |
| 23 | MP0002009_preneoplasia | 2.07208493 |
| 24 | MP0005636_abnormal_mineral_homeostasis | 1.89209680 |
| 25 | MP0001666_abnormal_nutrient_absorption | 1.79193644 |
| 26 | MP0003252_abnormal_bile_duct | 1.67087302 |
| 27 | MP0000465_gastrointestinal_hemorrhage | 1.66824820 |
| 28 | MP0000230_abnormal_systemic_arterial | 1.60177065 |
| 29 | MP0000462_abnormal_digestive_system | 1.58226608 |
| 30 | MP0004782_abnormal_surfactant_physiolog | 1.56162462 |
| 31 | MP0002796_impaired_skin_barrier | 1.41716915 |
| 32 | MP0005360_urolithiasis | 1.36084035 |
| 33 | MP0005166_decreased_susceptibility_to | 1.30184518 |
| 34 | MP0001756_abnormal_urination | 1.24612494 |
| 35 | MP0000537_abnormal_urethra_morphology | 1.22557572 |
| 36 | MP0002098_abnormal_vibrissa_morphology | 1.20361229 |
| 37 | MP0005409_darkened_coat_color | 1.19736446 |
| 38 | MP0003303_peritoneal_inflammation | 1.18827104 |
| 39 | MP0009643_abnormal_urine_homeostasis | 1.17051163 |
| 40 | MP0000467_abnormal_esophagus_morphology | 1.16671011 |
| 41 | MP0002136_abnormal_kidney_physiology | 1.15575863 |
| 42 | MP0003724_increased_susceptibility_to | 1.13668424 |
| 43 | MP0008872_abnormal_physiological_respon | 1.08934460 |
| 44 | MP0000470_abnormal_stomach_morphology | 1.06946652 |
| 45 | MP0002277_abnormal_respiratory_mucosa | 1.05062470 |
| 46 | MP0000678_abnormal_parathyroid_gland | 1.04286365 |
| 47 | MP0003283_abnormal_digestive_organ | 1.03231018 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.02252499 |
| 49 | MP0003300_gastrointestinal_ulcer | 1.01914318 |
| 50 | MP0001485_abnormal_pinna_reflex | 1.01647572 |
| 51 | MP0005310_abnormal_salivary_gland | 1.00894085 |
| 52 | MP0001188_hyperpigmentation | 0.99404221 |
| 53 | MP0010678_abnormal_skin_adnexa | 0.98814718 |
| 54 | MP0005319_abnormal_enzyme/_coenzyme | 0.97113244 |
| 55 | MP0003045_fibrosis | 0.95413565 |
| 56 | MP0002896_abnormal_bone_mineralization | 0.94967839 |
| 57 | MP0002006_tumorigenesis | 0.94123781 |
| 58 | MP0001501_abnormal_sleep_pattern | 0.91699838 |
| 59 | MP0002822_catalepsy | 0.90535517 |
| 60 | MP0004019_abnormal_vitamin_homeostasis | 0.90417285 |
| 61 | MP0000566_synostosis | 0.90147956 |
| 62 | MP0005666_abnormal_adipose_tissue | 0.88954780 |
| 63 | MP0009785_altered_susceptibility_to | 0.86976115 |
| 64 | MP0002876_abnormal_thyroid_physiology | 0.86305448 |
| 65 | MP0004484_altered_response_of | 0.84050726 |
| 66 | MP0005501_abnormal_skin_physiology | 0.82130804 |
| 67 | MP0001764_abnormal_homeostasis | 0.78597541 |
| 68 | MP0010329_abnormal_lipoprotein_level | 0.77012101 |
| 69 | MP0002118_abnormal_lipid_homeostasis | 0.75139142 |
| 70 | MP0005595_abnormal_vascular_smooth | 0.74229469 |
| 71 | MP0003879_abnormal_hair_cell | 0.73244139 |
| 72 | MP0005165_increased_susceptibility_to | 0.70574720 |
| 73 | MP0000538_abnormal_urinary_bladder | 0.70212621 |
| 74 | MP0004858_abnormal_nervous_system | 0.68586826 |
| 75 | MP0005332_abnormal_amino_acid | 0.68408638 |
| 76 | MP0000609_abnormal_liver_physiology | 0.68312069 |
| 77 | MP0009780_abnormal_chondrocyte_physiolo | 0.64785182 |
| 78 | MP0003693_abnormal_embryo_hatching | 0.61942135 |
| 79 | MP0000613_abnormal_salivary_gland | 0.60842808 |
| 80 | MP0003567_abnormal_fetal_cardiomyocyte | 0.60486570 |
| 81 | MP0002971_abnormal_brown_adipose | 0.60307706 |
| 82 | MP0001216_abnormal_epidermal_layer | 0.59828049 |
| 83 | MP0004947_skin_inflammation | 0.59495343 |
| 84 | MP0004215_abnormal_myocardial_fiber | 0.58098251 |
| 85 | MP0009115_abnormal_fat_cell | 0.57411640 |
| 86 | MP0003953_abnormal_hormone_level | 0.56978744 |
| 87 | MP0002733_abnormal_thermal_nociception | 0.56771086 |
| 88 | MP0001845_abnormal_inflammatory_respons | 0.55761116 |
| 89 | MP0005025_abnormal_response_to | 0.55040673 |
| 90 | MP0003329_amyloid_beta_deposits | 0.53905304 |
| 91 | MP0001849_ear_inflammation | 0.51457249 |
| 92 | MP0000377_abnormal_hair_follicle | 0.51417171 |
| 93 | MP0008875_abnormal_xenobiotic_pharmacok | 0.50996391 |
| 94 | MP0004270_analgesia | 0.49202238 |
| 95 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.49144085 |
| 96 | MP0008961_abnormal_basal_metabolism | 0.49090220 |
| 97 | MP0006082_CNS_inflammation | 0.47641919 |
| 98 | MP0005448_abnormal_energy_balance | 0.47516918 |
| 99 | MP0002148_abnormal_hypersensitivity_rea | 0.47403768 |
| 100 | MP0009333_abnormal_splenocyte_physiolog | 0.46071387 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Metabolic alkalosis (HP:0200114) | 8.67705086 |
| 2 | Decreased circulating renin level (HP:0003351) | 8.15495264 |
| 3 | Abnormality of renin-angiotensin system (HP:0000847) | 7.91662223 |
| 4 | Flat acetabular roof (HP:0003180) | 7.03607508 |
| 5 | Abnormality of chloride homeostasis (HP:0011422) | 6.25330206 |
| 6 | Hyperaldosteronism (HP:0000859) | 5.96794815 |
| 7 | Alkalosis (HP:0001948) | 5.27572513 |
| 8 | Neonatal short-limb short stature (HP:0008921) | 5.09372829 |
| 9 | Right ventricular cardiomyopathy (HP:0011663) | 4.79699361 |
| 10 | Hyponatremia (HP:0002902) | 4.75281596 |
| 11 | Flat capital femoral epiphysis (HP:0003370) | 4.70365960 |
| 12 | Flattened epiphyses (HP:0003071) | 4.41533144 |
| 13 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 4.32639816 |
| 14 | Conjugated hyperbilirubinemia (HP:0002908) | 4.21391656 |
| 15 | Hypokalemia (HP:0002900) | 4.13914409 |
| 16 | Abdominal distention (HP:0003270) | 4.06677339 |
| 17 | Abnormality of potassium homeostasis (HP:0011042) | 4.03309348 |
| 18 | Ileus (HP:0002595) | 3.95045357 |
| 19 | Hyperkalemia (HP:0002153) | 3.92128724 |
| 20 | Visceral angiomatosis (HP:0100761) | 3.60769821 |
| 21 | Abnormality of sodium homeostasis (HP:0010931) | 3.57108874 |
| 22 | Intrahepatic cholestasis (HP:0001406) | 3.56628329 |
| 23 | Spinal cord compression (HP:0002176) | 3.56247975 |
| 24 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.53757306 |
| 25 | Large earlobe (HP:0009748) | 3.39192513 |
| 26 | Vertebral clefting (HP:0008428) | 3.36965104 |
| 27 | Breech presentation (HP:0001623) | 3.33907439 |
| 28 | Abnormal vertebral ossification (HP:0100569) | 3.25782451 |
| 29 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 3.24773262 |
| 30 | Vertebral hypoplasia (HP:0008417) | 3.24773262 |
| 31 | Hemangiomatosis (HP:0007461) | 3.23270737 |
| 32 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 3.15367011 |
| 33 | Abnormal biliary tract morphology (HP:0012440) | 3.00574474 |
| 34 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.98284020 |
| 35 | Adrenal overactivity (HP:0002717) | 2.94565158 |
| 36 | Irregular epiphyses (HP:0010582) | 2.94125346 |
| 37 | Abnormal tarsal ossification (HP:0008369) | 2.91851767 |
| 38 | Hip contracture (HP:0003273) | 2.82245870 |
| 39 | Hemorrhage of the eye (HP:0011885) | 2.71193094 |
| 40 | Malnutrition (HP:0004395) | 2.62011403 |
| 41 | Pili torti (HP:0003777) | 2.61706389 |
| 42 | Abnormal cartilage morphology (HP:0002763) | 2.60725174 |
| 43 | Syncope (HP:0001279) | 2.58053687 |
| 44 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.55079202 |
| 45 | Congenital sensorineural hearing impairment (HP:0008527) | 2.48807765 |
| 46 | Cystic hygroma (HP:0000476) | 2.43716742 |
| 47 | Curly hair (HP:0002212) | 2.40085964 |
| 48 | Palpitations (HP:0001962) | 2.37291357 |
| 49 | Hoarse voice (HP:0001609) | 2.36491143 |
| 50 | Dehydration (HP:0001944) | 2.34440638 |
| 51 | Renal tubular acidosis (HP:0001947) | 2.33282532 |
| 52 | Abnormality of carpal bone ossification (HP:0006257) | 2.30882731 |
| 53 | Hydroxyprolinuria (HP:0003080) | 2.29531085 |
| 54 | Abnormality of proline metabolism (HP:0010907) | 2.29531085 |
| 55 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.21116264 |
| 56 | Villous atrophy (HP:0011473) | 2.21116264 |
| 57 | Abnormal foot bone ossification (HP:0010675) | 2.20953025 |
| 58 | Chronic bronchitis (HP:0004469) | 2.20870024 |
| 59 | Fat malabsorption (HP:0002630) | 2.20704209 |
| 60 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.20405301 |
| 61 | Biliary tract neoplasm (HP:0100574) | 2.18201758 |
| 62 | Ventricular fibrillation (HP:0001663) | 2.13973742 |
| 63 | Abnormality of the 1st metacarpal (HP:0010009) | 2.12883871 |
| 64 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.12766589 |
| 65 | Short middle phalanx of finger (HP:0005819) | 2.09880008 |
| 66 | Stillbirth (HP:0003826) | 2.08635041 |
| 67 | Abnormal hand bone ossification (HP:0010660) | 2.00794016 |
| 68 | Hyperactive renin-angiotensin system (HP:0000841) | 11.5191219 |
| 69 | Focal segmental glomerulosclerosis (HP:0000097) | 1.99943289 |
| 70 | Abnormal hair laboratory examination (HP:0003328) | 1.97009451 |
| 71 | Chronic diarrhea (HP:0002028) | 1.96762193 |
| 72 | Abnormality of vitamin B metabolism (HP:0004340) | 1.93744564 |
| 73 | Severe short stature (HP:0003510) | 1.91598169 |
| 74 | Hip dysplasia (HP:0001385) | 1.90858177 |
| 75 | Limited hip movement (HP:0008800) | 1.89318025 |
| 76 | Increased circulating renin level (HP:0000848) | 1.87987468 |
| 77 | Increased density of long bones (HP:0006392) | 1.84515070 |
| 78 | Abnormal ossification of hand bones (HP:0005921) | 1.79167966 |
| 79 | Rectal prolapse (HP:0002035) | 1.76248403 |
| 80 | Bundle branch block (HP:0011710) | 1.73484349 |
| 81 | Neoplasm of the rectum (HP:0100743) | 1.71714124 |
| 82 | Thin bony cortex (HP:0002753) | 1.70463173 |
| 83 | Hyperparathyroidism (HP:0000843) | 1.68194972 |
| 84 | Bone cyst (HP:0012062) | 1.68177869 |
| 85 | Short phalanx of the thumb (HP:0009660) | 1.66589907 |
| 86 | Neoplasm of the small intestine (HP:0100833) | 1.66518118 |
| 87 | Protuberant abdomen (HP:0001538) | 1.66282609 |
| 88 | Hypotension (HP:0002615) | 1.65140083 |
| 89 | Broad metatarsal (HP:0001783) | 1.64244121 |
| 90 | Abnormality of the acetabulum (HP:0003170) | 1.58920726 |
| 91 | Abnormality of vitamin metabolism (HP:0100508) | 1.58834106 |
| 92 | Late onset (HP:0003584) | 1.58035441 |
| 93 | Hyperammonemia (HP:0001987) | 1.54869833 |
| 94 | Toxemia of pregnancy (HP:0100603) | 1.53530070 |
| 95 | Glomerulosclerosis (HP:0000096) | 1.52727507 |
| 96 | Renal salt wasting (HP:0000127) | 1.51633056 |
| 97 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.49936988 |
| 98 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 1.48655721 |
| 99 | Thickened nuchal skin fold (HP:0000474) | 1.48498239 |
| 100 | Overfolded helix (HP:0000396) | 1.48203525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIK3CA | 6.86889163 |
| 2 | ACVR1B | 6.21689809 |
| 3 | MST1R | 5.77271411 |
| 4 | LMTK2 | 5.01635876 |
| 5 | EPHA2 | 4.64165083 |
| 6 | RIPK1 | 3.65331379 |
| 7 | STK24 | 2.93469331 |
| 8 | STK39 | 2.88450416 |
| 9 | MET | 2.35634066 |
| 10 | EPHB2 | 2.29229197 |
| 11 | FRK | 1.87170069 |
| 12 | WNK4 | 1.85302468 |
| 13 | OXSR1 | 1.83827855 |
| 14 | PRKG2 | 1.82663821 |
| 15 | MAP3K10 | 1.45659232 |
| 16 | MYLK | 1.33557841 |
| 17 | PTK6 | 1.24771890 |
| 18 | ERN1 | 1.15085060 |
| 19 | MAPKAPK3 | 1.13561615 |
| 20 | PDK2 | 1.09692806 |
| 21 | MAP3K12 | 1.04780000 |
| 22 | PRKAA2 | 0.99549079 |
| 23 | TAOK3 | 0.98350483 |
| 24 | DDR2 | 0.94794614 |
| 25 | ERBB2 | 0.90222130 |
| 26 | CAMK2D | 0.86459304 |
| 27 | TNIK | 0.85783635 |
| 28 | STK3 | 0.84236129 |
| 29 | MAP2K2 | 0.84109911 |
| 30 | RIPK4 | 0.78672825 |
| 31 | MAP3K2 | 0.78093448 |
| 32 | PDPK1 | 0.78046543 |
| 33 | MAPK11 | 0.77760516 |
| 34 | MAP2K6 | 0.77121071 |
| 35 | MATK | 0.71969380 |
| 36 | EPHB1 | 0.67438850 |
| 37 | ABL2 | 0.61773678 |
| 38 | EPHA3 | 0.60984322 |
| 39 | GRK1 | 0.60933478 |
| 40 | PDK1 | 0.59404063 |
| 41 | TESK2 | 0.58465451 |
| 42 | FGFR3 | 0.55893876 |
| 43 | TRPM7 | 0.53273522 |
| 44 | TAOK1 | 0.52503694 |
| 45 | EEF2K | 0.52138270 |
| 46 | NLK | 0.49850369 |
| 47 | CDK19 | 0.49359251 |
| 48 | PRKACG | 0.47769057 |
| 49 | ADRBK2 | 0.47467519 |
| 50 | MST4 | 0.44710839 |
| 51 | TYK2 | 0.44005383 |
| 52 | MAPKAPK2 | 0.43888196 |
| 53 | TESK1 | 0.42511949 |
| 54 | WNK1 | 0.41554083 |
| 55 | SRC | 0.41259631 |
| 56 | ADRBK1 | 0.41100523 |
| 57 | MAP2K1 | 0.41022547 |
| 58 | IRAK1 | 0.40289670 |
| 59 | PRKCA | 0.39536081 |
| 60 | CASK | 0.38957419 |
| 61 | INSRR | 0.38629925 |
| 62 | PRKAA1 | 0.38605564 |
| 63 | FER | 0.37463887 |
| 64 | RPS6KA2 | 0.35220401 |
| 65 | CSNK1A1 | 0.33543667 |
| 66 | PTK2 | 0.32433768 |
| 67 | CDC42BPA | 0.31916563 |
| 68 | DMPK | 0.31363331 |
| 69 | FGFR4 | 0.30521934 |
| 70 | BMPR2 | 0.28557338 |
| 71 | MUSK | 0.28028743 |
| 72 | EPHA4 | 0.26418760 |
| 73 | PRPF4B | 0.25592770 |
| 74 | GRK6 | 0.25512899 |
| 75 | FYN | 0.25406760 |
| 76 | RPS6KA6 | 0.24756188 |
| 77 | PNCK | 0.24622057 |
| 78 | RET | 0.23906751 |
| 79 | PRKCB | 0.23601693 |
| 80 | BMPR1B | 0.23461984 |
| 81 | ROCK1 | 0.22344532 |
| 82 | IGF1R | 0.22057465 |
| 83 | MAPK7 | 0.21408795 |
| 84 | MELK | 0.20938648 |
| 85 | PRKCQ | 0.20854674 |
| 86 | MAP3K1 | 0.20602259 |
| 87 | NTRK1 | 0.18408811 |
| 88 | PRKCE | 0.18306454 |
| 89 | CHUK | 0.18037071 |
| 90 | PAK4 | 0.17748930 |
| 91 | LYN | 0.17533371 |
| 92 | NEK6 | 0.15922576 |
| 93 | STK38L | 0.15186116 |
| 94 | JAK2 | 0.14790422 |
| 95 | RPS6KB1 | 0.14310004 |
| 96 | MAP3K14 | 0.14189491 |
| 97 | PRKCD | 0.13790887 |
| 98 | YES1 | 0.13628573 |
| 99 | PRKCZ | 0.13413353 |
| 100 | SGK1 | 0.13377746 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 5.17883068 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.90797030 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 4.35596049 |
| 4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.56543006 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.39381418 |
| 6 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.99527244 |
| 7 | Mineral absorption_Homo sapiens_hsa04978 | 2.76147417 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.71070964 |
| 9 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.54540043 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.32798461 |
| 11 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.00964465 |
| 12 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.94220819 |
| 13 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.93957748 |
| 14 | Retinol metabolism_Homo sapiens_hsa00830 | 1.90973143 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.88154204 |
| 16 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.84747124 |
| 17 | Bile secretion_Homo sapiens_hsa04976 | 1.84169264 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.78091672 |
| 19 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.77196178 |
| 20 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.75150351 |
| 21 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.70770013 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.64734849 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.62717935 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.58998300 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.50631796 |
| 26 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.44759984 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.42458914 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.40044083 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.23834020 |
| 30 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.20237149 |
| 31 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.10758735 |
| 32 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.10051552 |
| 33 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.07245682 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.97895171 |
| 35 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.96200827 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.94651208 |
| 37 | Renin secretion_Homo sapiens_hsa04924 | 0.94090395 |
| 38 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91520873 |
| 39 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88311901 |
| 40 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.86645880 |
| 41 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.80726295 |
| 42 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.76016633 |
| 43 | Tight junction_Homo sapiens_hsa04530 | 0.75472492 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70239300 |
| 45 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68756610 |
| 46 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68331107 |
| 47 | Asthma_Homo sapiens_hsa05310 | 0.67757459 |
| 48 | Other glycan degradation_Homo sapiens_hsa00511 | 0.67337884 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53428442 |
| 50 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.50298619 |
| 51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49916794 |
| 52 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49502098 |
| 53 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.49162319 |
| 54 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.48458706 |
| 55 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.45233408 |
| 56 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44633595 |
| 57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.44236687 |
| 58 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.40242752 |
| 59 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.37766630 |
| 60 | Allograft rejection_Homo sapiens_hsa05330 | 0.35822936 |
| 61 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.35612361 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 0.35491805 |
| 63 | Taste transduction_Homo sapiens_hsa04742 | 0.35454763 |
| 64 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35385231 |
| 65 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.35262538 |
| 66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34638177 |
| 67 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.33626603 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33471401 |
| 69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.32811250 |
| 70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.29007735 |
| 71 | Long-term depression_Homo sapiens_hsa04730 | 0.28592740 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.26920867 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.26774749 |
| 74 | Salivary secretion_Homo sapiens_hsa04970 | 0.26682978 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.26404780 |
| 76 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.26092210 |
| 77 | ABC transporters_Homo sapiens_hsa02010 | 0.25634458 |
| 78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.24836419 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.24280583 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.22851595 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21238354 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19728922 |
| 83 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.17615991 |
| 84 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.16794092 |
| 85 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.16734812 |
| 86 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.16221642 |
| 87 | Insulin secretion_Homo sapiens_hsa04911 | 0.15170622 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.14818955 |
| 89 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.13697554 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.12039218 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.10224530 |
| 92 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.07792112 |
| 93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.07638657 |
| 94 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.07507916 |
| 95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.05610174 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.05290168 |
| 97 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.03642041 |
| 98 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.02751104 |
| 99 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.02606819 |
| 100 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.01202076 |

